Brown Elizabeth E, Fallin Daniele, Ruczinski Ingo, Hutchinson Amy, Staats Brian, Vitale Francesco, Lauria Carmela, Serraino Diego, Rezza Giovanni, Mbisa Georgina, Whitby Denise, Messina Angelo, Goedert James J, Chanock Stephen J
National Cancer Institute, 6120 Executive Boulevard, EPS 8005/MSC 7248 Rockville, MD 20852, USA.
Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):926-34. doi: 10.1158/1055-9965.EPI-05-0791.
Classic Kaposi sarcoma (CKS) is an inflammatory-mediated neoplasm primarily caused by Kaposi sarcoma-associated herpesvirus (KSHV). Kaposi sarcoma lesions are characterized, in part, by the presence of proinflammatory cytokines and growth factors thought to regulate KSHV replication and CKS pathogenesis. Using genomic DNA extracted from 133 CKS cases and 172 KSHV-latent nuclear antigen-positive, population-based controls in Italy without HIV infection, we examined the risk of CKS associated with 28 common genetic variants in 14 immune-modulating genes. Haplotypes were estimated for IL1A, IL1B, IL4, IL8, IL8RB, IL10, IL12A, IL13, and TNF. Compared with controls, CKS risk was decreased with 1235T/-1010G-containing diplotypes of IL8RB (odds ratio, 0.49; 95% confidence interval, 0.30-0.78; P = 0.003), whereas risk was increased with diplotypes of IL13 containing the promoter region variant 98A (rs20541, alias +130; odds ratio, 1.88; 95% confidence interval, 1.15-3.08; P = 0.01) when considered in multivariate analysis. Risk estimates did not substantially vary by age, sex, incident disease, or disease burden. Our data provide preliminary evidence for variants in immune-modulating genes that could influence the risk of CKS. Among KSHV-seropositive Italians, CKS risk was associated with diplotypes of IL8RB and IL13, supporting laboratory evidence of immune-mediated pathogenesis.
经典型卡波西肉瘤(CKS)是一种主要由卡波西肉瘤相关疱疹病毒(KSHV)引起的炎症介导的肿瘤。卡波西肉瘤病变部分特征在于存在促炎细胞因子和生长因子,这些因子被认为可调节KSHV复制和CKS发病机制。我们使用从133例CKS病例和172例意大利无HIV感染的KSHV潜伏核抗原阳性的人群对照中提取的基因组DNA,研究了与14个免疫调节基因中28个常见基因变异相关的CKS风险。对白细胞介素1A(IL1A)、白细胞介素1B(IL1B)、白细胞介素4(IL4)、白细胞介素8(IL8)、白细胞介素8受体B(IL8RB)、白细胞介素10(IL10)、白细胞介素12A(IL12A)、白细胞介素13(IL13)和肿瘤坏死因子(TNF)进行单倍型估计。与对照组相比,含有IL8RB的1235T/-1010G双倍型的CKS风险降低(比值比为0.49;95%置信区间为0.30 - 0.78;P = 0.003),而在多变量分析中,含有启动子区域变异98A(rs20541,别名+130)的IL13双倍型的风险增加(比值比为1.88;95%置信区间为1.15 - 3.08;P =